| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 56.174 | 88.887 | 114.409 | 107.809 | 111.689 | 144.198 | 161.807 |
| Total Income - EUR | - | - | - | 57.572 | 89.696 | 116.482 | 107.915 | 140.998 | 144.227 | 188.835 |
| Total Expenses - EUR | - | - | - | 27.449 | 35.991 | 37.952 | 39.350 | 88.399 | 74.141 | 292.489 |
| Gross Profit/Loss - EUR | - | - | - | 30.123 | 53.705 | 78.530 | 68.565 | 52.599 | 70.086 | -103.654 |
| Net Profit/Loss - EUR | - | - | - | 29.547 | 52.808 | 77.444 | 67.486 | 51.189 | 68.644 | -109.319 |
| Employees | - | - | - | 4 | 4 | 2 | 2 | 5 | 5 | 4 |
Check the financial reports for the company - Sanmar Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.083 | 35.824 | 27.050 | 18.534 | 48.500 | 46.458 | 34.955 |
| Current Assets | - | - | - | 30.169 | 56.423 | 77.986 | 117.828 | 91.368 | 107.588 | 35.959 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 6.634 | 9.657 | 9.330 | 10.203 | 12.355 | 103.400 | 5.458 |
| Cash | - | - | - | 23.536 | 46.767 | 68.656 | 107.625 | 79.013 | 4.188 | 30.501 |
| Shareholders Funds | - | - | - | 29.590 | 52.850 | 77.485 | 67.527 | 51.230 | 68.685 | -109.279 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.662 | 39.398 | 27.550 | 68.835 | 88.639 | 85.361 | 180.193 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanmar Health S.r.l.